FDA approves anti-obesity drug as first sleep apnea medication
The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Washington Examiner10 天
FDA approves anti-obesity drug as first sleep apnea medication
The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine for obstructive sleep apnea, marking a major shift in the treatment ...
Pharmaceutical Technology1 天
Liraglutide by Novo Nordisk for Obesity: Likelihood of Approval
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could ...
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
Yahoo11 天
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea. A doctor who says he's reversed his age by 20 years shares the 6 bare ...
Makkah13 天Opinion
The Rapid Growth of the Anti-Obesity Drug Market
Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Honolulu Star-Advertiser11 天
New weight-loss treatment becomes first FDA-approved drug for sleep apnea
The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the ...
CNN11 天
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...
Investing11 天
FDA expands approval for obesity drug to include young children
BOSTON - The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Rhythm Pharmaceuticals' (NASDAQ:RYTM) obesity drug, IMCIVREE (setmelanotide), now including children as ...
WTAE-TV11 天
FDA says knockoff versions of Lilly obesity drug must come off the market
Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity ... they pay.Zepbound is FDA-approved to treat obesity and Mounjaro is ...